NM_001124758.3:c.16T>C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001124758.3(SPNS2):āc.16T>Cā(p.Cys6Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,015,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001124758.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000205 AC: 3AN: 146676Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000276 AC: 24AN: 868924Hom.: 0 Cov.: 29 AF XY: 0.0000321 AC XY: 13AN XY: 405194
GnomAD4 genome AF: 0.0000205 AC: 3AN: 146676Hom.: 0 Cov.: 32 AF XY: 0.0000280 AC XY: 2AN XY: 71314
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.16T>C (p.C6R) alteration is located in exon 1 (coding exon 1) of the SPNS2 gene. This alteration results from a T to C substitution at nucleotide position 16, causing the cysteine (C) at amino acid position 6 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at